Synthetic peptides derived from the Wilms' tumor 1 protein sensitize human T lymphocytes to recognize chronic myelogenous leukemia cells.
Hematol J. 2003;4(1):57-66. doi: 10.1038/sj.thj.6200220.
Hematol J. 2003.
PMID: 12692522